You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0226 Sustained effectiveness of methotrexate with step-down glucocorticoid remission induction (cobra slim) for early rheumatoid arthritis in a treat-to- target setting: 2-year results of the carera trial

Citation Tools

Article menu

Download PDFPDF

Oral Presentations
From classics to new: synthetic DMARDs in RA
OP0226 Sustained effectiveness of methotrexate with step-down glucocorticoid remission induction (cobra slim) for early rheumatoid arthritis in a treat-to- target setting: 2-year results of the carera trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Stouten V, Joly J, Cock DD, et al
OP0226 Sustained effectiveness of methotrexate with step-down glucocorticoid remission induction (cobra slim) for early rheumatoid arthritis in a treat-to- target setting: 2-year results of the carera trial
Annals of the Rheumatic Diseases 2017;76:147.